FDA Sets Date for Crucial Nanotechnology Meeting

FDA announced that on October 10 it will hold a public meeting on FDA-regulated products containing nanotechnology materials. The agency wants to learn what nanotechnology products are under development and whether any scientific issues should be brought to its attention. It is extremely important that industry give the agency a thorough appraisal of how nanotech is being used. FDA is still feeling its way around the nanotech landscape, and a consistent strategy on how to regulate nanotech products has not yet emerged. This is industry's chance to help develop one. Registration is already open, and electronic comments may be submitted in advance of the meeting, which will be held in Bethesda, MD. (Make sure to reference Docket No. 2006N-0107.)